Royalty Pharma plc Class A Ordinary Shares (RPRX)
Royalty Pharma plc Class A Ordinary Shares (RPRX) has reported earnings 20 times since Aug 11, 2021. The stock moves an average of ±2.22% the day after reporting, closing higher 55.0% of the time. Its largest post-earnings gain was +6.83% (Nov 05, 2025) and its largest decline was -5.8% (May 05, 2022). The next earnings report is predicted for 2026-08-07 (high confidence).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±2.22%
Positive %
55.0%
Negative %
45.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 06, 2026 | ☀ PRE | $51.49 | $51.49 | $50.68 | 218,921 | +0.45% | open_in_new |
| Feb 11, 2026 | ☀ PRE | $43.17 | $45.23 | $44.28 | 285,356 | +0.11% | open_in_new |
| Nov 05, 2025 | ☀ PRE | $36.27 | $40.80 | $40.44 | 472,473 | +6.83% | open_in_new |
| Aug 06, 2025 | ☀ PRE | $37.08 | $37.77 | $37.08 | 198,796 | -2.22% | open_in_new |
| May 08, 2025 | ☀ PRE | $32.65 | $34.11 | $33.11 | 393,683 | +0.98% | open_in_new |
| Feb 11, 2025 | ☀ PRE | $31.62 | $32.69 | $32.23 | 428,408 | +1.51% | open_in_new |
| Nov 06, 2024 | ☀ PRE | $28.00 | $28.35 | $26.64 | 144,623 | -3.3% | open_in_new |
| Aug 08, 2024 | ☀ PRE | $27.40 | $27.41 | $26.16 | 216,104 | -4.04% | open_in_new |
| May 09, 2024 | ☀ PRE | $28.64 | $28.68 | $27.95 | 77,352 | -0.18% | open_in_new |
| Feb 15, 2024 | ☀ PRE | $29.62 | $30.82 | $30.03 | 126,184 | +2.53% | open_in_new |
| Nov 08, 2023 | ☀ PRE | $27.25 | $27.65 | $27.61 | 97,253 | +0.22% | open_in_new |
| Aug 08, 2023 | ☀ PRE | $30.13 | $30.73 | $30.54 | 53,563 | -0.84% | open_in_new |
| May 09, 2023 | ☀ PRE | $35.31 | $35.52 | $34.00 | 151,033 | -4.32% | open_in_new |
| Feb 15, 2023 | ☀ PRE | $37.95 | $38.47 | $37.67 | 82,269 | -0.8% | open_in_new |
| Nov 08, 2022 | ☀ PRE | $42.36 | $43.86 | $42.69 | 117,298 | +0.78% | open_in_new |
| Aug 04, 2022 | ☀ PRE | $42.54 | $43.14 | $42.51 | 65,183 | -0.75% | open_in_new |
| May 05, 2022 | ☀ PRE | $42.84 | $42.88 | $40.70 | 207,532 | -5.8% | open_in_new |
| Feb 15, 2022 | ☀ PRE | $39.44 | $40.54 | $40.34 | 128,536 | +3.09% | open_in_new |
| Nov 10, 2021 | ☀ PRE | $39.75 | $42.32 | $41.60 | 287,301 | +4.98% | open_in_new |
| Aug 11, 2021 | ☀ PRE | $37.30 | $37.43 | $36.66 | 127,031 | +0.71% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±2.22%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 4 | 20260608 | open_in_new SEC.gov |
| 8-K | 20260604 | open_in_new SEC.gov |
| 4 | 20260528 | open_in_new SEC.gov |
Frequently asked about RPRX earnings
When does Royalty Pharma plc Class A Ordinary Shares report earnings next? expand_more
Royalty Pharma plc Class A Ordinary Shares (RPRX)'s next earnings date is predicted (high confidence) for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does RPRX stock move after earnings? expand_more
Over 20 reports, RPRX has moved an average of ±2.22% the session after earnings, closing higher 55.0% of the time.
What was RPRX's biggest post-earnings move? expand_more
RPRX's largest post-earnings gain on record was +6.83% on Nov 05, 2025, and its largest decline was -5.8% on May 05, 2022.
Where can I find Royalty Pharma plc Class A Ordinary Shares's SEC filings? expand_more
All of Royalty Pharma plc Class A Ordinary Shares's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right